top of page

AGENDA

THURSDAY, March 20, 2025

 

7:00 AM–4:30 PM

Registration

​

7:15–8:00 AM 

Breakfast

 

Pediatric Connect I Breakout Session

Co-chairs/moderators: Carina Kugelmas, MD and Miriam Vos, MD, MSPH

 

8:00–8:10 AM 

Welcome

Miriam Vos, MD, MSPH

 

Part I: Hepatology Potpourri 

Moderators: Miriam Vos, MD, MSPH and Rohit Kohli, MBBS, MS

​

8:10–8:30 AM 

Lipodystrophy: Finding the Needle in the Haystack

Rebecca Brown, MD, MHSc

​

8:30–8:45 AM 

Modern Approaches in Mitochondrial Liver Disease

Ronald Sokol, MD 

​

8:45–9:15 AM

Cases for Contemplation: Panel Discussion – Case-Based

Rebecca Brown, MD, MHSc; Ryan Fischer, MD; Samar Ibrahim, MB, ChB; Ronald Sokol, MD; and Jeffrey Teckman, MD

 

Part II: Hepatology Potpourri

Moderators: Rima Fawaz, MD and Ronald Sokol, MD 

​

9:15–9:40 AM 

Keynote: Wilson Disease Emerging Challenges

Michael Schilsky, MD

​

9:40–10:00 AM 

Cases for Contemplation: Panel Discussion – Case-Based

Regino Gonzalez-Peralta, MD; Alyssa A. Kriegermeier, MD; Anna Peters, MD, PhD; and Michael Schilsky, MD

​

10:00–10:15 AM 

Break 

 

Part III: Pediatric Cholestatic Disease

Moderators: Regino Gonzalez-Peralta, MD and Nitika Gupta, MD

​

10:15–10:30 AM 

Nutritional Management: New Guidelines on Managing Fat-Soluble Vitamin Deficiency

Amal Aqul, MD

​

10:30–10:45 AM 

VOUS or Not? Clinical use of Genetic Panels for Cholestatic Disease 

Kathleen Loomes, MD

​

10:45–11:00 AM

Making the Case for Pruritus Treatment: Case-Based Examples of Therapeutic Decision-Making

Mercedes Martinez, MD

​

11:00–11:30 AM 

Cases for Contemplation: Panel Discussion – Case-Based

Amal Aqul, MD; Jaime Chu, MD; Karan Emerick, MD; Kathleen Loomes, MD; and Mercedes Martinez, MD

​

11:30–11:45 AM 

Pediatric Connect Closing 

Carina Kugelmas, MD

​

11:45 AM–12:15 PM 

Lunch​

​

12:15–1:00 PM 

Industry-Sponsored Event 
Iqirvo & Bylvay: Discover Treatment Options for Your Patients
Naim Alkhouri, MD 
Sponsored by: Ipsen Biopharmaceuticals

La Cantera Ballroom

​

1:00–1:15 PM 

Break/Visit Exhibits

 

1:15–1:30 PM 

Welcome and Introductions

Zobair Younossi, MD, MPH

​

1:30–2:00 PM 

Keynote: Finding Happiness in Your Career

Patrick Kamath, MD

​

Session I: Autoimmune Cholestatic Liver Disease 

Advances in PBC, PSC, and Autoimmune Hepatitis 

Co-chairs: Kris Kowdley, MD and Raj Vuppalanchi, MD

​

2:00–2:20 PM  

Current Landscape in PBC Diagnosis and Treatment

Kris Kowdley, MD

 

2:20–2:35 PM  

Debate: Second-Line Therapy Options in PBC

Moderator: John Vierling, MD

Aparna Goel, MD and Craig Lammert, MD

​

2:35–2:55 PM  

Assessment and Therapy of Symptoms in PBC

Mark Swain, MD, MSc

​

2:55–3:15 PM  

Q&A / Panel Discussion 

 

3:15–3:30 PM  

Break / Visit Exhibits

​

3:30–3:45 PM  

Spotlight on Drug-Induced Autoimmune Hepatitis and Immune-Mediated Liver Injury from Checkpoint Inhibitors

Lily Dara, MD

​

3:45–4:00 PM 

Overview of PSC: Mechanisms and Emerging Therapies

​Christopher Bowlus, MD

​

4:00–4:15 PM  

Updates in Autoimmune Hepatitis

Craig Lammert, MD

​

4:15–4:30 PM  

Q&A / Panel Discussion 

​

4:30–4:45 PM

Break / Visit Exhibits

 

Session II: Alcohol-Associated Liver Disease

New Horizons in Treating Alcohol-Associated Hepatitis: Therapies, Strategies, and Debates

Co-chairs: Steven Flamm, MD; Mack Mitchell, MD; and Ashwani Singal, MD, MS  

​

4:45–5:05 PM

Recognition and Treatment of Compensated ALD/MetALD

Ashwani Singal, MD, MS

​

5:05–5:25 PM

Treatment of AUD in Patients with ALD

Mack Mitchell, MD

​

5:25–5:45 PM

Early Liver Transplant for ALD: What Defines Success After Transplant?

Sarah Lieber, MD, MSCR

​

5:45–6:00 PM

Q&A / Panel Discussion

​

6:00–7:00 PM

Satellite Symposium (Non-Accredited) 

Expert Perspectives on the Unmet Needs in Patients With Wilson Disease
Sammy Saab, MD, MPH and Regino Gonzalez-Peralta, MD

Supported by an educational grant from Orphalan.

FRIDAY, March 21, 2025

 

7:00 AM–4:45 PM  

Registration

​

7:15–7:45 AM  

Breakfast

​

7:45–8:30 AM

Industry-Sponsored Event

A Deep Dive into MASH: Exploring the Role of Metabolic Dysfunction in Disease Pathophysiology

Steven Flamm, MD

Sponsored by: Novo Nordisk

​

8:30–9:00 AM

Break / Visit Exhibits 

​

Session III: MASLD/MASH

Innovations in MASLD Management: From NITs to Multidisciplinary Approaches and Extrahepatic Comorbidities
Co-chairs: Alina Allen, MD and Zobair Younossi, MD, MPH

​

9:00–9:05 AM

Welcome Back

Zobair Younossi, MD, MPH 

​

9:05 AM–9:35 AM

Keynote: The Evolution of MASH and Fibrosis Over Decades

Scott Friedman, MD

​

9:35 AM–9:50 AM

Practical Use of NITs
Alina Allen, MD

​

9:50–10:15 AM

Expert Panel Discussion: The Role of NITs
Moderator: Naim Alkhouri, MD

Panelists: Alina Allen, MD; Mandeep Bajaj, MD; and Scott Friedman, MD

​

10:15–10:30 AM

Break / Visit Exhibits

​

10:30–10:45 AM

Current Management: Obesity and Type-2 Diabetes in MASLD

Christos Mantzoros, MD

​

10:45–11:00 AM

MASH Targeted Therapy-Current and Future

Manal Abdelmalek, MD, MPH

​

11:00–11:25 AM

Expert Panel Discussion: Management of MASLD

Moderator: Zobair Younossi, MD, MPH

Panelists: Manal Abdelmalek, MD, MPH; Mandeep Bajaj, MD; Scott Isaacs, MD; and Christos Mantzoros, MD, DSc, PhD

​

11:25–11:40 AM

Extrahepatic Diseases Associated with MASLD (CVD, CKD, Cancer, and Sarcopenia)

Naim Alkhouri, MD

​

11:40–11:55 AM

Role of Multi-Disciplinary Team in MASLD Management 

Mazen Noureddin, MD, MHSc

​

11:55 AM–12:20 PM

Expert Panel Discussion: Models of Care

Moderator: Sonal Kumar, MD MPH

Panelists: Michael Betel, MS, MSc; Scott Isaacs, MD;  Christos Mantzoros, MD, DSc, PhD; and Mazen Noureddin, MD, MHSc

​

12:20–12:30 PM

Session Wrap-up

Zobair Younossi, MD, MPH

​

12:30–1:00 PM

Lunch

​

1:00–1:45 PM

Industry-Sponsored Event

Clinical Deep Dive: Unlocking the Treatment Potential of Rezdiffra

Sujit Janardhan, MD and Carmen Landaverde, MD 

Sponsored by: Madrigal Pharmaceuticals

​​

1:45–2:00 PM

Break / Visit Exhibits 

​

Session IV: Cirrhosis

Advancing Care in Cirrhosis: A Case-Based Approach to Alpha-1 Antitrypsin Deficiency, Portal Hypertension, and Acute-on-Chronic Liver Failure
Co-chairs: Marcelo Kugelmas, MD and Sammy Saab, MD, MPH

 

2:00–2:10 PM

Session Introduction

Marcelo Kugelmas, MD

 

2:10–2:40 PM 

Part I: Alpha-1 Antitrypsin Deficiency and Cirrhosis 

Ranjeeta Bahirwani, MD; Arun Jesudian, MD; Paul Kwo, MD; Mina Rakoski, MD; and Sammy Saab, MD, MPH

 

2:40–3:10 PM 

Part II: Cirrhosis and Portal Hypertension 

Marcelo Kugelmas, MD; Carmen Landaverde, MD; Akshay Shetty, MD; and Robert Wong, MD, MS

 

3:10–3:40 PM 

Part III: Acute-on-Chronic Liver Failure 

David S. Goldberg, MD, MSCE; Sammy Saab, MD, MPH; Monica Tincopa, MD, MS; Hirsh D. Trivedi, MD, MS; and Kali Zhou, MD

​

3:40–3:45 PM

Case Wrap-up 

​

3:45–4:00 PM

Break / Visit Exhibits

​

4:00–4:05 PM

Keynote Introduction

Marcelo Kugelmas, MD 

​

4:05–4:35 PM

Keynote: Management of Portal Vein Thrombosis

Steven Flamm, MD

​

4:35–4:50 PM

Q&A / Panel Discussion 

​

4:50–5:00 PM

Wrap-up

Marcelo Kugelmas, MD

​​

5:00–6:00 PM

Accredited Symposium 

Bridging the Gap: Strategies to Advance Equity in Liver Disease Care

Kimberly Brown, MD, Lily Dara, MD, Nadege Gunn, MD, CPI, Tatyana Kushner, MD, MSCE, and Nancy Reau, MD 

Supported by an educational grant from Gilead Sciences, Inc. 

​​​

6:00–7:00 PM I Breakout Session

Pediatric MASLD Roundtable Discussion 

Co-chairs: Carina Kugelmas, MD and Miriam Vos, MD, MSPH

Rohit Kohli, MBBS, MS; Marialena Mouzaki, MD, MSc; Jennifer Panganiban, MD;
Jeffrey Schwimmer, MD; and Stavra Xanthakos, MD, MS

 

7:00–8:30 PM

Conference Reception & Poster Display 

SATURDAY, March 22, 2025

 

7:15–7:45 AM

Breakfast

​

7:45–8:30 AM 

Industry-Sponsored Event
Clinical Insights Into a First-in-Class Treatment for Primary Biliary Cholangitis (PBC)
Kimberly Brown, MD
Sponsored by: Gilead Sciences

​

8:30–9:00 AM
Break / Visit Exhibits

 

9:00–9:05 AM 

Welcome Back

Ira Jacobson, MD 

​

Session V: Viral Hepatitis
Co-chairs: Ira Jacobson, MD and Paul Martin, MD

​

9:00–9:20 AM

Exploring the Nuances of Hepatitis Vaccination: Are We Doing Enough?

Paul Kwo, MD ​

​​

9:20–9:40 AM

Navigating Expanding Guidelines for Hepatitis B: Which Are Right for Your Patients?

Douglas Dieterich, MD

​

9:40–10:00 AM

Emerging Treatments for Hepatitis B on the Horizon

Ira Jacobson, MD

​

10:00–10:20 AM

Hepatitis D: Strategies for Treatment and Management

Tatyana Kushner, MD, MSCE

​

10:20–10:40 AM

HBV Case Discussion

Moderated by Paul Martin, MD

​

10:40–11:00 AM

Q&A / Panel Discussion

​

11:00–11:15 AM

Break / Visit Exhibits


Session VI: HCC

Advances in Liver Cancer Therapy: IR, Systemic Treatments, and Neoadjuvant Approaches

Co-chairs: Aijaz Ahmed, MD; Laura Kulik, MD; and Robert Wong, MD, MS

​

11:15–11:30 AM

Locoregional Therapy for Locally Advanced HCC

Siddharth Padia, MD

​

11:30–11:40 AM 

How Do Systemic Therapies and LRT Fit into the Treatment of Unresectable HCC?

Laura Kulik, MD 

​

11:40–11:55 AM 

Evolving Role of Neoadjuvant Systemic Therapy for Transplant 

Parissa Tabrizian, MD

​

11:55 AM–12:15 PM 

Q&A / Panel Discussion 

​

12:15–12:30 PM 

Closing Remarks

Marcelo Kugelmas, MD

​_________________________________​

​

1:30–3:00 PM I Breakout Session

APP Session

Aijaz Ahmed, MD, Christina Hanson, FNP and Marcelo Kugelmas, MD

​

1:30–3:30 PM I Breakout Session

Fellows Summit

Kimberly Brown, MD, Steven Flamm, MD and Robert Wong, MD

  • Facebook
  • YouTube
  • LinkedIn

© 2025 Focus Medical Communications, LLC

bottom of page